Solid Biosciences SLDB Balance Sheet (2017-2026)

NASDAQ SLDB
$10.25 -0.17 (-1.63%)
At close: Sep 4, 2026 · 4:00 PM EDT
Reported Financials

Solid Biosciences Quarterly Balance Sheet

Periods 38 quarters
Latest Jun 2026

Solid Biosciences reported total assets of $420.58M and total liabilities of $46.51M for the quarter ended Jun 2026, up 36.4% year over year. This balance sheet covers 38 quarters of results from Mar 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Accumulated Depreciation
10.90M11.66M12.37M13.09M9.42M10.96M10.86M11.56M12.15M12.73M13.05M13.03M14.19M
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
109.68M119.14M129.71M54.31M48.79M155.38M164.65M91.57M49.04M74.02M117.57M95.85M64.39M80.23M210.63M138.93M61.36M59.90M297.10M159.39M
Receivables - NetNet Receivables
0.11M
Receivables - OtherOther Receivables
0.59M0.11M0.01M
Receivables
0.22M
Prepaid Assets
8.37M14.72M18.54M7.32M5.12M5.92M5.09M7.28M5.46M6.09M8.13M7.34M8.38M8.38M6.49M10.53M8.71M16.38M15.47M16.79M
Current Assets
238.81M222.61M198.61M170.44M147.51M219.64M190.60M167.47M148.35M129.73M214.19M197.61M179.49M157.30M313.41M278.64M244.85M205.46M396.79M395.11M
Non-Current Assets
Property, Plant & Equipment (Net)
6.89M6.46M6.10M6.85M6.27M9.66M8.61M7.39M7.04M6.62M6.39M5.44M5.07M4.75M4.48M4.32M4.36M4.17M3.91M3.96M
Other Non-Current Assets
2.07M2.07M2.07M1.83M1.83M1.83M1.83M1.83M1.83M1.83M1.83M1.91M1.93M1.95M1.97M1.92M1.92M0.77M1.30M1.30M
Non-Current Assets
10.18M9.77M8.95M38.06M36.97M40.61M38.98M37.25M36.38M35.20M34.50M33.37M32.33M31.36M30.50M29.65M29.06M27.08M26.11M25.47M
Assets
248.99M232.38M207.56M208.50M184.47M260.25M229.59M204.72M184.73M164.94M248.69M230.98M211.83M188.66M343.90M308.29M273.91M232.54M422.89M420.58M
Liabilities
Current Liabilities
Accounts Payables
4.15M4.46M4.76M5.11M5.15M3.24M5.59M2.97M1.90M2.03M1.73M2.52M3.46M4.24M6.44M4.70M8.43M3.22M5.56M4.36M
Notes Payables
3.40M3.15M4.80M5.70M6.55M9.20M3.35M4.20M
Payables
4.15M4.46M4.76M5.11M5.15M3.24M5.59M2.97M1.90M2.03M1.73M2.52M6.86M7.39M11.24M10.40M14.98M12.42M8.91M8.56M
Accumulated Expenses
8.00M9.53M9.44M16.14M10.28M16.69M12.38M10.51M11.47M10.16M10.33M9.92M13.23M19.85M14.58M16.55M19.05M18.95M19.18M17.79M
Other Accumulated Expenses
0.07M0.04M0.15M0.02M0.09M0.01M0.06M0.12M0.16M0.02M0.09M
Current Leases
1.23M1.26M0.98M0.41M1.06M1.90M1.86M1.85M1.85M1.85M1.69M1.72M1.72M1.79M1.87M1.94M2.03M2.10M2.19M2.23M
Current Deferred Revenue
8.87M8.08M6.17M
Total Current Liabilities
22.54M23.60M21.74M21.72M16.93M22.51M20.29M15.87M15.82M14.52M14.34M14.69M22.85M30.26M28.78M29.85M36.34M33.47M30.28M28.58M
Non-Current Liabilities
Capital Leases
0.35M0.29M0.23M1.70M1.60M1.48M1.36M1.23M1.10M0.95M0.31M
Non-Current Deffered Revenue
2.26M
Operating Leases
0.47M0.28M0.07M24.54M24.27M24.28M23.91M23.64M23.19M22.71M22.53M22.09M21.64M21.16M20.66M20.16M19.62M19.06M18.48M17.92M
Other Non-Current Liabilities
0.10M3.40M
Total Non-Current Liabilities
48.49M23.94M23.05M21.95M21.16M20.66M20.16M19.62M19.06M18.48M17.92M
Total Liabilities
25.62M24.17M22.05M46.26M41.20M48.59M45.80M40.99M40.37M38.46M37.97M37.74M44.80M51.42M49.44M50.00M55.97M52.53M48.76M46.51M
Shareholder's Equity
Total Debt
3.40M3.15M4.80M5.70M6.55M9.20M3.35M4.20M
Common Equity
223.36M208.21M185.51M300.00M143.28M211.67M183.79M163.73M144.36M126.48M210.72M193.25M167.02M137.25M294.46M258.29M217.95M180.01M374.13M374.07M
Liabilities and Shareholders Equity
248.99M232.38M207.56M208.50M184.47M260.25M229.59M204.72M184.73M164.94M248.69M230.98M211.83M188.66M343.90M308.29M273.91M232.54M422.89M420.58M
Retained Earnings
-458.15M-476.76M-502.08M-527.18M-547.59M-562.74M-592.81M-617.44M-638.42M-658.75M-683.10M-708.13M-740.90M-783.45M-822.73M-862.21M-907.99M-957.77M-1014.51M-1069.31M